News

Latest news and events from Oxford MEStar

Oxford MEStar announces non-binding LOI with Elanix Biotechnologies

PRESS RELEASE Oxford MEStar announces non-binding letter of intent with Elanix Biotechnologies in regard to setting up a JV to market GynRepair in China Oxford, 22 November, 2016 Oxford MEStar Ltd (“MEStar”), an Oxford University spin-out, today announced that the company has entered into a non-binding letter of intent (LOI) with Elanix Biotechnologies AG.  The […]


Oxford MEStar to develop diagnostic products in cancer and infectious diseases using intellectual property acquired from University of Glasgow spin-out, Mode Diagnostics Limited.

Oxford MEStar Ltd (“MEStar”), an Oxford University spin-out, has acquired selected intellectual property, trademarks and assets from Mode Diagnostics Ltd (“Mode”) for an undisclosed sum. Professor Zhanfeng Cui, the founder of MEStar, commented: “We are excited about the long term commercial potential of using this technology. We believe the IP developed by Mode, a proprietary […]


Partnership with UCL and Collagen Solutions Plc in grant funded project

Oxford MEStar Ltd, a rapidly growing company specialising in translational and regenerative medicine, announces that it is part of a consortium that has been awarded an Arthritis Research UK (ARUK) Point of Care grant to develop novel functionally man-made osteochondral scaffold for large osteochondral defect repairs. Osteochondral injury refers to repetitive trauma within a joint […]